在免疫疗法时代,去差异化脂肉瘤的治疗方法
Maggie Y Zhou1, Nam Q Bui1, Gregory W Charville2
1Sarcoma Program, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.
International journal of molecular sciences
|June 10, 2023
概括
区分良好的/不区分的脂质肉瘤 (WDLPS/DDLPS) 的治疗是有限的. 本综述涵盖了WDLPS/DDLPS正在进行的临床试验,重点是CDK4/6,MDM2和免疫检查点抑制剂.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 区分良好的/不区分的脂质肉瘤 (WDLPS/DDLPS) 是常见的软组织肉瘤,治疗选择有限.
- 无论是WDLPS还是DDLPS,它们都有12q13-15染色体放大,包括CDK4和MDM2基因.
- 由于更高的放大比率和额外的基因组变化,DDLPS表现出更具侵略性的行为.
研究的目的:
- 审查WDLPS/DDLPS中新疗法的已完成和正在进行的临床试验.
- 讨论CDK4/6抑制剂,MDM2抑制剂和免疫检查点抑制剂的潜力.
- 探索用于预测对免疫检查点抑制剂反应的生物标志物.
主要方法:
- 在WDLPS/DDLPS的临床试验的文献综述.
- 对WDLPS/DDLPS特征的遗传变化的分析.
- 讨论治疗策略和生物标志物评估.
主要成果:
- 由于缺乏化疗反应,WDLPS主要用局部疗法治疗.
- DDLPS对目前的化疗方案的反应有限.
- 新兴疗法包括CDK4/6抑制剂,MDM2抑制剂和免疫检查点抑制剂.
结论:
- 对于WDLPS/DDLPS,正在研究新的治疗策略.
- 针对性疗法和免疫疗法显示出有希望的结果.
- 生物标志物识别对于个性化治疗方法至关重要.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K